2-Bromo-5-methylpyrimidine → HCID 71208294, compound
Reaction equation
[CH3:1][S:2]([N:5]1[CH2:10][CH:9]=[C:8]([C:11]2[CH:12]=[C:13]3[CH2:19][C@H:18]([CH:20]4[CH2:25][CH2:24][NH:23][CH2:22][CH2:21]4)[O:17][C:14]3=[CH:15][N:16]=2)[CH2:7][CH2:6]1)(=[O:4])=[O:3].Br[C:27]1[N:32]=[CH:31][C:30]([CH3:33])=[CH:29][N:28]=1>>[CH3:1][S:2]([N:5]1[CH2:6][CH:7]=[C:8]([C:11]2[CH:12]=[C:13]3[CH2:19][C@H:18]([CH:20]4[CH2:25][CH2:24][N:23]([C:27]5[N:32]=[CH:31][C:30]([CH3:33])=[CH:29][N:28]=5)[CH2:22][CH2:21]4)[O:17][C:14]3=[CH:15][N:16]=2)[CH2:9][CH2:10]1)(=[O:3])=[O:4]Participants
3
Procedure
The title compound is prepared from (R)-5-(1-methanesulfonyl-1,2,3,6-tetrahydro-pyridin-4-yl)-2-piperidin-4-yl-2,3-dihydro-furo[2,3-c]pyridine (Intermediate 39, the configuration of the stereocenter is arbitrarily assigned) and 2-bromo-5-methylpyrimidine following a procedure analogous to that described in Example 1. LC (method 5): tR=0.84 min; Mass spectrum (ESI+): m/z=456 [M+H]+.
Sources & evidence
- ORD record
- ord-d0064d4a02cf4fe08667875410ea2c4e
- Source dataset
- uspto-grants-2014_07
- Patent number
- US08778926B2
Reaction notes
Loading…